187 related articles for article (PubMed ID: 9561949)
1. Novel antipsychotic medications and the treatment of comorbid substance abuse in schizophrenia.
Buckley PF
J Subst Abuse Treat; 1998; 15(2):113-6. PubMed ID: 9561949
[TBL] [Abstract][Full Text] [Related]
2. What is the relationship between schizophrenia and substance abuse?
Green AI
Harv Ment Health Lett; 2000 Oct; 17(4):8. PubMed ID: 11015759
[No Abstract] [Full Text] [Related]
3. Management of schizophrenia with substance use disorders.
Lybrand J; Caroff S
Psychiatr Clin North Am; 2009 Dec; 32(4):821-33. PubMed ID: 19944886
[TBL] [Abstract][Full Text] [Related]
4. Use of lamotrigine to augment clozapine in patients with resistant schizophrenia and comorbid alcohol dependence: a potent anti-craving effect?
Kalyoncu A; Mirsal H; Pektas O; Unsalan N; Tan D; Beyazyürek M
J Psychopharmacol; 2005 May; 19(3):301-5. PubMed ID: 15888516
[TBL] [Abstract][Full Text] [Related]
5. Clozapine use in patients with schizophrenia and a comorbid substance use disorder: A systematic review.
Arranz B; Garriga M; García-Rizo C; San L
Eur Neuropsychopharmacol; 2018 Feb; 28(2):227-242. PubMed ID: 29273271
[TBL] [Abstract][Full Text] [Related]
6. Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: a retrospective survey.
Zimmet SV; Strous RD; Burgess ES; Kohnstamm S; Green AI
J Clin Psychopharmacol; 2000 Feb; 20(1):94-8. PubMed ID: 10653215
[TBL] [Abstract][Full Text] [Related]
7. Clozapine for substance-abusing schizophrenic patients.
Tsuang JW; Eckman TE; Shaner A; Marder SR
Am J Psychiatry; 1999 Jul; 156(7):1119-20. PubMed ID: 10401473
[No Abstract] [Full Text] [Related]
8. Substance abuse in schizophrenia: a review.
Buckley PF
J Clin Psychiatry; 1998; 59 Suppl 3():26-30. PubMed ID: 9541335
[TBL] [Abstract][Full Text] [Related]
9. Pharmacotherapy for schizophrenia and co-occurring substance use disorders.
Green AI
Neurotox Res; 2007 Jan; 11(1):33-40. PubMed ID: 17449446
[TBL] [Abstract][Full Text] [Related]
10. Efficacy, acceptability and tolerability of antipsychotics in patients with schizophrenia and comorbid substance use. A systematic review and meta-analysis.
Krause M; Huhn M; Schneider-Thoma J; Bighelli I; Gutsmiedl K; Leucht S
Eur Neuropsychopharmacol; 2019 Jan; 29(1):32-45. PubMed ID: 30472164
[TBL] [Abstract][Full Text] [Related]
11. Substance abuse in clozapine-treated schizophrenic patients.
Sand PG; Soyka M
J Neuropsychiatry Clin Neurosci; 1997; 9(4):626-7. PubMed ID: 9447510
[No Abstract] [Full Text] [Related]
12. Treatment of schizophrenia and comorbid substance abuse: pharmacologic approaches.
Green AI
J Clin Psychiatry; 2006; 67 Suppl 7():31-5; quiz 36-7. PubMed ID: 16961422
[TBL] [Abstract][Full Text] [Related]
13. Clozapine for comorbid substance use disorder and schizophrenia: do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine?
Green AI; Zimmet SV; Strous RD; Schildkraut JJ
Harv Rev Psychiatry; 1999; 6(6):287-96. PubMed ID: 10370435
[TBL] [Abstract][Full Text] [Related]
14. Pharmacotherapy of schizophrenia with comorbid substance use disorder--reviewing the evidence and clinical recommendations.
Wobrock T; Soyka M
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1375-85. PubMed ID: 18394768
[TBL] [Abstract][Full Text] [Related]
15. Substance abuse and the management of medication nonadherence in schizophrenia.
Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
[TBL] [Abstract][Full Text] [Related]
16. Clozapine treatment in patients with prior substance abuse.
Kelly DL; Gale EA; Conley RR
Can J Psychiatry; 2003 Mar; 48(2):111-4. PubMed ID: 12655909
[TBL] [Abstract][Full Text] [Related]
17. Antipsychotic drug treatment of schizophrenic patients with substance abuse disorders.
San L; Arranz B; Martinez-Raga J
Eur Addict Res; 2007; 13(4):230-43. PubMed ID: 17851245
[TBL] [Abstract][Full Text] [Related]
18. Relationship of clinical symptoms and substance use in schizophrenia patients on conventional versus atypical antipsychotics.
Scheller-Gilkey G; Woolwine BJ; Cooper I; Gay O; Moynes KA; Miller AH
Am J Drug Alcohol Abuse; 2003 Aug; 29(3):553-66. PubMed ID: 14510040
[TBL] [Abstract][Full Text] [Related]
19. Pharmacotherapy of patients with schizophrenia and substance abuse.
Wobrock T; Soyka M
Expert Opin Pharmacother; 2009 Feb; 10(3):353-67. PubMed ID: 19191675
[TBL] [Abstract][Full Text] [Related]
20. Pharmacotherapy for schizophrenia and co-occurring substance use disorders.
Noordsy DL; Green AI
Curr Psychiatry Rep; 2003 Oct; 5(5):340-6. PubMed ID: 13678553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
